UP

US approves new drug to treat Alzheimer's disease

Home page Science
12 Punto 14 Punto 16 Punto 18 Punto

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

Axar.az reports the FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticised in a congressional report for its green-lighting of another Alzheimer's drug, Aduhelm.

And it was granted despite trial results showing the monoclonal antibody treatment carries risks of brain swelling and bleeding.

Both drugs were approved through an accelerated process that allows the FDA to fast-track approval of drugs for serious conditions where there is an unmet medical need.

Date
2023.01.07 / 11:38
Author
Axar.az
See also

Turkish Fergani's 1st satellite launched into space - Video

Former Georgian PM has been attacked

Iran-Russia agreement excludes military alliance

Aykhan Hajizada responded to US Embassy

Oil prices fall again on global markets

US may remove Cuba from sponsor of terrorism list

Austin urges 50bln dollars boost in US defense spending

Moldova’s anti-Russian policy could end Its existence

South Korean president Yoon Suk Yeol arrested

Blinken: Iran can make nuclear weapons in weeks

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla